View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Feb. 8 (HealthDay News) -- Screening for maternal hypothyroidism, and treatment of women with positive results, is not associated with improved IQ in offspring at age 3, according to a study published in the Feb. 9 issue of the New England Journal of Medicine.
John H. Lazarus, M.D., from the Cardiff School of Medicine in the United Kingdom, and colleagues investigated whether antenatal screening and treatment for hypothyroidism was associated with improved cognitive outcomes in offspring at 3 years of age. A total of 21,846 women, with a median gestational age of 12 weeks and 3 days, provided blood samples for which thyrotropin and free thyroxine levels were measured immediately (screening group) or shortly after birth (controls). Women in the screening group who tested positive were treated with levothyroxine. IQ of the child was measured by psychologists at age 3.
The investigators found positive results for hypothyroidism in 390 women in the screening group and 404 in the control group. Treatment with levothyroxine was started in those in the screening group at a median gestational age of 13 weeks and 3 days. The mean IQ scores among children of women with positive results were 99.2 in the screening group and 100.0 in the control group (P = 0.40 by intention-to-treat analysis). The proportion of children with an IQ of less than 85 was 12.1 and 14.1 percent in the screening and control groups, respectively (P = 0.39).
"Current guidelines do not recommend routine antenatal screening for hypothyroidism in pregnancy. Our study provides support for these guidelines, since we found no benefit of routine screening for maternal hypothyroidism at about 12 to 13 weeks' gestation in the prevention of impaired childhood cognitive function," the authors write.
One of the study authors disclosed financial ties to the pharmaceutical industry.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top